10 /100
LOW RISK
Score updated Jul 13, 2026

WST — West Pharmaceutical Services, Inc. Dilution Risk Tracker

Track WST dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track WST — Get alerts when the score changes →

As of July 13, 2026, West Pharmaceutical Services, Inc. (WST) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. West Pharmaceutical Services, Inc. has a market capitalization of $22.81B, 70.65M shares outstanding, 757 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
0
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for WST.
🔔 Track WST — Get forecast alerts →

💹 Market Data

Market Cap$22.81B
Shares Outstanding70.65M
Float70.16M
Cash$529.90M
Debt$205.00M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 17.5% shares (2026Q1 vs prior)
757 institutional holders · 84.52M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 9.37M shares
#2 BlackRock, Inc. 6.84M shares
#3 MORGAN STANLEY 4.47M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.32M
Days to Cover2.3
% of Float3.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for WST Shareholders

West Pharmaceutical Services, Inc. (WST) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for WST shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for WST in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for WST alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track WST Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking WST — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for WST
📊 WST FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 WST Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.